NT_1170x120_1-11-18

mylan

Mylan releases Cleocin generic in U.S.

Mylan releases Cleocin generic in U.S.

PITTSBURGH — Mylan N.V. has launched clindamycin palmitate hydrochloride oral solution 75 mg/5 ml, an antibiotic, in the United States. Mylan said Friday that its product is a generic version of Cleocin solution by Pharmacia/Upjohn (Pfizer) . Mylan received final approval from the Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for

Mylan releases generic Doryx DR tablets

Mylan releases generic Doryx DR tablets

PITTSBURGH — Mylan N.V. has launched doxycycline hyclate delayed-release tablets (200 mg), an antibiotic, in the United States. Mylan said its doxycycline product is a generic version of Doryx 200-mg delayed-release tablets from Mayne Pharma. A tetracycline-class antimicrobial, doxycycline hyclate DR tablets are a indicated as adjunctive therapy for severe acne. U.S. sales of 200-mg doxycycline

Mylan to acquire Renaissance topicals business

Mylan to acquire Renaissance topicals business

PITTSBURGH — Mylan N.V. has entered an agreement to buy the nonsterile, topicals-focused specialty and generics business of Renaissance Acquisition Holdings LLC for $950 million in cash. Mylan said Friday that the Renaissance business, which has about 1,200 employees and posted sales of $370 million in 2015, will bring 25 branded and generic topical products,

Mylan adds more dosages for Lopressor generic

Mylan adds more dosages for Lopressor generic

PITTSBURGH —  Mylan N.V. has launched metoprolol tartrate tablets, a hypertension drug, in dosages of 37.5 mg and 75 mg in the United States. Mylan said its products, a generic version of Lopressor tablets from Novartis, are the first and only available intermediate dosage strengths between the current metoprolol tartrate tablets, which come in strengths

Mylan releases generic version of Ultram

Mylan releases generic version of Ultram

PITTSBURGH — Mylan N.V. has rolled out tramadol hydrochloride extended-release tablets, a chronic pain medication, in the United States. The drug maker said its product comes in dosages of 100 mg, 200 mg and 300 mg and is a generic version of Ultram ER tablets from Valeant Pharmaceuticals International. Tramadol hydrochloride ER tablets are indicated

GPhA tabs Mylan’s Bresch to chair board

GPhA tabs Mylan’s Bresch to chair board

ORLANDO, Fla. — The Generic Pharmaceutical Association (GPhA) has elected Heather Bresch, chief executive officer of Mylan, to chair its board of directors this year. GPhA, which announced the move at its 2016 Annual Meeting here, also named other officers to its 2016 board and executive committee: Jeff Watson, president of global generics at Apotex,

Mylan to acquire Meda in $9.9 billion deal

Mylan to acquire Meda in $9.9 billion deal

HERTFORDSHIRE, England — Mylan N.V. plans to acquire Sweden-based pharmaceuticals manufacturer Meda AB in a deal valued at $9.9 billion, including debt. Mylan said late Wednesday that the offer to Meda includes cash and Mylan shares, with the equity portion valued at $7.2 billion. Executives from both companies noted that a Mylan-Meda combination would create

Mylan, Teva release generics of Ortho Tri-Cyclen Lo

Mylan, Teva release generics of Ortho Tri-Cyclen Lo

NEW YORK — Mylan N.V. and Teva Pharmaceutical Industries Ltd. have rolled out norgestimate/ethinyl estradiol tablets, a birth control pill, in the United States. The companies said Tuesday that their products are generic versions of Janssen Pharmaceuticals Inc.’s Ortho Tri-Cyclen Lo tablets. Mylan said its norgestimate/ethinyl estradiol tablets — available in dosages of 0.18 mg/0.025

Mylan names GSK veteran as global OTC leader

Mylan names GSK veteran as global OTC leader

HERTFORDSHIRE, England, and PITTSBURGH — Mylan N.V. has tabbed GlaxoSmithKline Consumer Healthcare veteran Ranjan Ray Chaudhuri to serve as global commercial lead of Mylan’s over-the-counter business. Chaudhuri will report to Rajiv Malik, president of Mylan. “The opportunity to build upon Mylan’s one-of-a-kind global platform and contribute to the organization’s ongoing evolution is tremendously exciting to

Mylan takes hostile bid to Perrigo stockholders

Mylan takes hostile bid to Perrigo stockholders

HERTFORDSHIRE, England — As promised, Mylan N.V. has proceeded to make formal bid to acquire Perrigo Co. plc in a deal valued at approximately $27 billion. Mylan said Monday that under the offer, Perrigo shareholders would receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share. That would translate to a

Yasmin generic released by Mylan

Yasmin generic released by Mylan

PITTSBURGH — Mylan N.V. has announced the U.S. launch of drospirenone and ethinyl estradiol tablets (3 mg/0.03 mg), an oral contraceptive. Mylan said Tuesday that the product, a generic version of Yasmin tablets from Bayer, is available immediately and represents its 13th oral contraceptive launch in the United States. Mylan’s partner Famy Care Ltd. received